BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31816355)

  • 1. Palmitate and oleate modify membrane fluidity and kinase activities of INS-1E β-cells alongside altered metabolism-secretion coupling.
    Oberhauser L; Granziera S; Colom A; Goujon A; Lavallard V; Matile S; Roux A; Brun T; Maechler P
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118619. PubMed ID: 31816355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucolipotoxicity promotes the capacity of the glycerolipid/NEFA cycle supporting the secretory response of pancreatic beta cells.
    Oberhauser L; Jiménez-Sánchez C; Madsen JGS; Duhamel D; Mandrup S; Brun T; Maechler P
    Diabetologia; 2022 Apr; 65(4):705-720. PubMed ID: 35018486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity.
    Li J; Liu X; Ran X; Chen J; Li X; Wu W; Huang H; Huang H; Long Y; Liang J; Cheng J; Tian H
    Diabetes Obes Metab; 2010 Jan; 12(1):35-46. PubMed ID: 19758361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oleate rescues INS-1E β-cells from palmitate-induced apoptosis by preventing activation of the unfolded protein response.
    Sommerweiss D; Gorski T; Richter S; Garten A; Kiess W
    Biochem Biophys Res Commun; 2013 Nov; 441(4):770-6. PubMed ID: 24189472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6 cells exposed to oleate compared to palmitate.
    Thörn K; Bergsten P
    J Cell Biochem; 2010 Oct; 111(2):497-507. PubMed ID: 20524206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate.
    Frigerio F; Chaffard G; Berwaer M; Maechler P
    Biochem Pharmacol; 2006 Oct; 72(8):965-73. PubMed ID: 16934763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism.
    Frigerio F; Brun T; Bartley C; Usardi A; Bosco D; Ravnskjaer K; Mandrup S; Maechler P
    Diabetologia; 2010 Feb; 53(2):331-40. PubMed ID: 19908022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitate-induced changes in protein expression of insulin secreting INS-1E cells.
    Hovsepyan M; Sargsyan E; Bergsten P
    J Proteomics; 2010 Apr; 73(6):1148-55. PubMed ID: 20117255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1.
    Roche E; Buteau J; Aniento I; Reig JA; Soria B; Prentki M
    Diabetes; 1999 Oct; 48(10):2007-14. PubMed ID: 10512366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of metabolic and morphological changes associated with chronic exposure of pancreatic islet beta-cells to fatty acids.
    Pinnick K; Neville M; Clark A; Fielding B
    J Cell Biochem; 2010 Mar; 109(4):683-92. PubMed ID: 20069570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleic acid protects insulin-secreting INS-1E cells against palmitic acid-induced lipotoxicity along with an amelioration of ER stress.
    Liu X; Zeng X; Chen X; Luo R; Li L; Wang C; Liu J; Cheng J; Lu Y; Chen Y
    Endocrine; 2019 Jun; 64(3):512-524. PubMed ID: 30778898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1.
    Brun T; Assimacopoulos-Jeannet F; Corkey BE; Prentki M
    Diabetes; 1997 Mar; 46(3):393-400. PubMed ID: 9032094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleate protects beta-cells from the toxic effect of palmitate by activating pro-survival pathways of the ER stress response.
    Sargsyan E; Artemenko K; Manukyan L; Bergquist J; Bergsten P
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1151-1160. PubMed ID: 27344025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells.
    Segall L; Lameloise N; Assimacopoulos-Jeannet F; Roche E; Corkey P; Thumelin S; Corkey BE; Prentki M
    Am J Physiol; 1999 Sep; 277(3):E521-8. PubMed ID: 10484365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?
    Lameloise N; Muzzin P; Prentki M; Assimacopoulos-Jeannet F
    Diabetes; 2001 Apr; 50(4):803-9. PubMed ID: 11289045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells.
    Kwon B; Lee HK; Querfurth HW
    Biochim Biophys Acta; 2014 Jul; 1843(7):1402-13. PubMed ID: 24732014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose- and Time-Dependent Effects of Oleate on Mitochondrial Fusion/Fission Proteins and Cell Viability in HepG2 Cells: Comparison with Palmitate Effects.
    de Sousa IF; Migliaccio V; Lepretti M; Paolella G; Di Gregorio I; Caputo I; Ribeiro EB; Lionetti L
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in mitochondrial carriers exhibit stress-specific signatures in INS-1Eβ-cells exposed to glucose versus fatty acids.
    Brun T; Scarcia P; Li N; Gaudet P; Duhamel D; Palmieri F; Maechler P
    PLoS One; 2013; 8(12):e82364. PubMed ID: 24349266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion.
    Warnotte C; Nenquin M; Henquin JC
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):147-53. PubMed ID: 10459862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose Responsiveness of β-Cells Depends on Fatty Acids.
    Gerst F; Singer C; Noack K; Graf D; Kaiser G; Panse M; Kovarova M; Schleicher E; Häring HU; Drews G; Ullrich S
    Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):644-653. PubMed ID: 30986881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.